These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4454451)

  • 1. [Antithrombotic effect of acetylsalicylic acid, heparin and phenprocoumon on the formation of experimental coagulation thrombi].
    Zimmermann R; Barth P; Masche R
    Verh Dtsch Ges Inn Med; 1974; 80():1446-8. PubMed ID: 4454451
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs and herbal remedies that affect blood clotting.
    Wynn RL; Bergman SA
    Gen Dent; 2002; 50(6):484-8, 490. PubMed ID: 12572177
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis of novel 3-carboxamide-benzocoumarin derivatives as orally active antithrombotic agents.
    Sashidhara KV; Kumar A; Kumar M; Singh S; Jain M; Dikshit M
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7034-40. PubMed ID: 22004722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings: The antithrombotic effect of acetylsalicylic acid, heparin and phenprocoumon in experimental thrombosis.
    Barth P; Zimmermann R; Zieboll J; Lange D
    Thromb Diath Haemorrh; 1975 Nov; 34(2):554-5. PubMed ID: 1198427
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of agents which modify platelet behaviour and of magnesium ions on thrombus formation in vivo.
    Adams JH; Mitchell JR
    Thromb Haemost; 1979 Aug; 42(2):603-10. PubMed ID: 505367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
    Zabolotskikh IB; Sin'kov SV; Klevko VA
    Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative study of antithrombotic and antiaggregatory activity of acetylsalicylic acid, ticlopidine and a new noncarboxylic acid antiinflammatory pyrazine derivative HF90.
    Petrusewicz J; Siluk D; Kaliszan R; Foks H; Nowakowska E
    Acta Pol Pharm; 1999; 56(6):463-7. PubMed ID: 10715891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings: The effect of sulphinpyrazone, sodium aspirin and oxprenolol on the formation of arterial platelet thrombi.
    Lewis GP; Westwick J
    Br J Pharmacol; 1975 Oct; 55(2):255P-256P. PubMed ID: 1201396
    [No Abstract]   [Full Text] [Related]  

  • 10. The pharmacology of aspirin, heparin, coumarin, and thrombolytic agents. Implications for therapeutic use in cardiopulmonary disease.
    Kessler CM
    Chest; 1991 Apr; 99(4 Suppl):97S-112S. PubMed ID: 2009817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
    Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
    Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of sodium salicylate, acetylsalicylate, 2, 3-dihydroxybenzoic and 2, 3-diacetoxybenzoic acids on the blood coagulation system and the elimination of heparin].
    Ermakova NV
    Farmakol Toksikol; 1975; 38(4):445-9. PubMed ID: 1213133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of antithrombotic activity of heparin, ASA, sulfinpyrazone and VK 744 in a rat model of arterial thrombosis.
    Philp RB; Francey I; Warren BA
    Haemostasis; 1978; 7(5):282-93. PubMed ID: 689491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-generation agents: aspirin, heparin and coumarins.
    Mueller RL
    Best Pract Res Clin Haematol; 2004 Mar; 17(1):23-53. PubMed ID: 15171956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of acetylsalicylic acid in anticoagulation therapy].
    Barth P; Walter E; Zimmermann R; Weber E
    Dtsch Med Wochenschr; 1972 Dec; 97(48):1854-9. PubMed ID: 4564650
    [No Abstract]   [Full Text] [Related]  

  • 16. Coagulation for cardiologists.
    Wessler S; Gitel SN
    Am Heart J; 1978 Dec; 96(6):811-23. PubMed ID: 362880
    [No Abstract]   [Full Text] [Related]  

  • 17. Defibrotide affects the anticoagulant and lipase-releasing activities of heparin.
    Porta R; Pescador R; Mantovani M; Prino G
    Haemostasis; 1990; 20(6):347-56. PubMed ID: 2099323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slight differences in sulfation of algal galactans account for differences in their anticoagulant and venous antithrombotic activities.
    Fonseca RJ; Oliveira SN; Melo FR; Pereira MG; Benevides NM; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):539-45. PubMed ID: 18327402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonpeptide factor Xa inhibitors: I. Studies with SF303 and SK549, a new class of potent antithrombotics.
    Wong PC; Quan ML; Crain EJ; Watson CA; Wexler RR; Knabb RM
    J Pharmacol Exp Ther; 2000 Jan; 292(1):351-7. PubMed ID: 10604970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.